Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Mimer Medical AB
AB
Active
Org 5564584729
Svärdvägen 3 B, 182 33
Danderyd
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1993 · 33 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Mimer Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
19M
14M
9M
5M
0M
2020: 15M
15M
2020
2021: 11M (-27% vs 2020)
11M
-27%
2021
2022: 2M (-82% vs 2021)
2M
-82%
2022
2023: 3M (+50% vs 2022)
3M
+50%
2023
2024: 10M (+233% vs 2023)
10M
+233%
2024
EBITDA
SEK millions
12M
7M
2M
-3M
-8M
2020: 8M
8M
2020
2021: -4M (-150% vs 2020)
-4M
-150%
2021
2022: -1M (+75% vs 2021)
-1M
+75%
2022
2023: 1M (+200% vs 2022)
1M
+200%
2023
2024: 4M (+300% vs 2023)
4M
+300%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
10 076
2 679
2 239
11 096
14 672
Staff expenses
—
—
—
—
—
EBITDA
3 776
930
−701
−4 067
7 683
Depreciation & amort.
−49
−0
−0
−0
−0
EBIT
3 727
930
−701
−4 067
7 683
Net financials
2 644
147 803
2 811
4 111
−99
Profit before tax
6 329
148 734
2 744
44
9 161
Tax
−297
−0
−0
−0
−279
Net profit
6 032
148 734
2 744
44
8 882
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
86 438
216 450
73 360
73 471
81 679
Equity
83 735
206 303
61 169
62 026
64 982
Long-term debt
0
0
0
0
0
Short-term debt
1 031
8 945
6 541
3 517
8 920
Total debt
1 031
8 945
6 541
3 517
8 920
Financial ratios
5-year trend
EBITDA margin
37,5 %
This company
15,8 %
Market median
This company
Market median
137% above market
2020
2024
Equity ratio
96,9 %
This company
38,2 %
Market median
This company
Market median
154% above market
2020
2024
Return on equity
7,2 %
This company
18,4 %
Market median
This company
Market median
61% below market
2020
2024
Net profit margin
59,9 %
This company
8,1 %
Market median
This company
Market median
640% above market
2020
2024
Asset turnover
0,12×
This company
1,12×
Market median
This company
Market median
89% below market
2020
2024
Debt / equity
0,03×
This company
0,62×
Market median
This company
Market median
95% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Mimer Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
